Healthcare Benchmarking Study
How institutional investors see healthcare’s largest companies
This sentiment tracking study covers 30 large-cap Healthcare companies, collecting subsector trend and company-specific KPIs. The blinded study collects quant/qual data via Fishbone’s proprietary healthcare panel of institutional investors and analysts.
30
Large-cap companies
5
Healthcare subsectors
7
Investment KPIs per company
60+
Respondents per wave
Product tour
See the subscriber dashboard
Company names are blurred. Overview · Subsectors · Company detail and scorecard · KPI trends and consensus · Segmentation · Quote repository · Chart builder
Research framework
What the study measures, and how the data gets used
Each wave, institutional investors rate the sector, the five subsectors and the companies they know best. The result is a consistent benchmark that management, IR, boards and investors can act on.
Diagnose
Surface candid views on the subjects hardest to raise directly: credibility, governance, capital allocation.
Benchmark
Score each company against its subsector peers and against prior waves to see where the narrative lands and where it slips.
Engage
Bring independent, defensible evidence of investor sentiment into board reporting and investor conversations.
Anticipate
Catch inflection points early as sentiment shifts across subsectors, regions and specialist investors.
Company KPIs
Rated 0–10 for every covered company · Benchmarked since August 2025
01
Attractiveness as Investment
Overall appeal of the stock, with open-ended reasons and what would improve it
02
Strategic Vision
Clarity and credibility of the long-term plan
03
Capital Allocation
Discipline in M&A, buybacks, dividends and R&D spend
04
Management Team
Confidence in leadership and execution track record
05
Financial Performance
Growth, margins and delivery against guidance
06
Operational Execution
Day-to-day delivery on the strategy
07
Commercial & Pipeline Portfolio
Growth outlook from products, pipeline and end-markets
Also collected each wave
Context that explains the scores
Familiarity
How well each respondent knows the company; only knowledgeable raters score it
Shareholder Communication
What investors want management and IR to communicate better
Subsector Outlook
Bullish/bearish view and KPI priorities for each of the five subsectors
Regulatory & Policy Exposure
Amount of exposure by subsector, and whether it is rising or falling
End-Market Growth
Direction of end-market growth potential by subsector
30 Companies · 5 Subsectors
Subsector editions available
Pharmaceuticals
Bristol Myers Squibb
Eli Lilly
Johnson & Johnson
Merck
Pfizer
Zoetis
Biotechnology
AbbVie
Biogen
BioMarin
CRISPR Therapeutics
Gilead Sciences
Moderna
Equipment & Supplies
Abbott
Baxter
Becton Dickinson
Boston Scientific
Medtronic
Solventum
Providers & Services
Centene
Cigna
CVS Health
Elevance Health
Humana
UnitedHealth Group
Life Sciences Tools
Avantor
Charles River Laboratories
Danaher
Illumina
IQVIA
Mettler-Toledo
Inside the dashboard
Every company, every KPI, every wave
Overview
Sector sentiment, key findings and the largest changes per wave
Company views
Each company across every KPI, against subsector peers
Compare & analyze
KPI trends, investor consensus and segmentation
Investor voice
Searchable, sorted and tagged interview quotes and open-ends
Tools & exports
Chart builder, relationship map, PNG and Excel exports
Methodology & panel
Recruited directly. Verified individually.
Fishbone targets, recruits, and verifies each individual respondent on a panel we built and manage in-house. No third parties. Invitations go to corporate-verified email accounts, post-survey metadata confirms identity, and respondents rate only the subsectors they know best.
100%
Direct contact outreach; no panel vendors
60+
Investors per wave, qualified by subsector knowledge
6–8
30+-minute follow-up interviews each wave
Who it’s for
Built for the people who shape and price the equity story
Investor relations
Test the equity story against how investors actually rate the company and its peers
C-suite and boards
Track investor confidence in management, strategy and capital allocation, wave over wave
Buy-side investors
See where peers agree or split on a name, and how that has shifted
Corp dev and strategy
Read investor reaction to deals, portfolio moves and subsector positioning
Advisors and banks
Bring independent investor perception data into client conversations
Subscription
Three ways to access the study
Fielded four consecutive quarters from August 2025 to June 2026; now produced semi-annually, each June and December.
1
Data access
Full dashboard access each June and December cycle.
2
Custom question additions
Add your own questions to a cycle to explore specific topics or issues. Available June and December, custom data is exclusive.
3
Full exclusive study
Investor day or big event coming up? We field one-time, company-specific studies during off-cycle period (March or September). All findings are exclusive.
Get in touch
Request information
Tell us your role and what you’re interested in. We’ll reply within two business days.
FAQ
How often is the study fielded?+
The study was fielded four consecutive quarters, from August 2025 through June 2026, and is now produced semi-annually each June and December. Full exclusive studies are fielded off-cycle in spring or fall.
How are respondents verified?+
Fishbone recruits every respondent directly from a panel it built and manages in-house, with invitations sent to corporate-verified email accounts. No panel vendors are used, and post-survey metadata is checked to confirm identity.
Do participants know who subscribes?+
No. The study is blind: subscribers are never disclosed to participants.
I'm a respondent. Is my feedback anonymous?+
Yes. All feedback is anonymous. Neither you nor your firm is ever attributed to your answers, and results are shown only in aggregate. Interview quotes are grouped by topic and never attributed.
Can we add our own questions to a wave?+
Yes. Custom questions can be added to a June or December cycle to explore specific topics or issues, and the custom data is exclusive to you.